Canada’s paediatric drug regulations put children at unnecessary risk

Canada remains one of the few developed nations without a 'paediatric rule,' leading many new drugs to be submitted without appropriate paediatric information.

We are not offering children the same regulatory protections as we do their parents, write Allison Chang, Deborah Levy, Charlotte Moore Hepburn, and ISG Senator Rosemary Moodie.Photograph courtesy of the Pan American Health Organization

Opinion

BY ALLISON CHANG, DEBORAH LEVY, CHARLOTTE MOORE HEPBURN, AND ISG SENATOR ROSEMARY MOODIE

April 6, 2022

Canada’s paediatric drug regulatory system is woefully out of date. This is a fact that we, as paediatric experts, must confront, and a burden that Canadian children and families must bear.

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy